Table 2:
Non-HDL cholesterol (mg/dL) levels and percent of participants on lipid treatment at exams 1 to 8 across model-based categories.
| Category | Sample Size | Follow-up | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Exam 1 | Exam 2 | Exam 3 | Exam 4 | Exam 5 | Exam 6 | Exam 7 | Exam 8 | ||
| Low | N=766 | 105.4±21.2 | 112.2±20.7 | 111.9±21.1 | 112.8±21.1 | 115.4±21.2 | 118.6±22.4 | 120.9±24.7 | 123.4±25.5 |
| 0.0% | 0.0% | 0.0% | 0.1% | 0.2% | 0.3% | 1.2% | 10.4% | ||
| Mid | N=1278 | 141.4±25.2 | 149.9±23.8 | 155.9±24.1 | 157.0±23.1 | 159.5±21.9 | 164.0±24.2 | 163.5±24.4 | 160.1±20.7 |
| 0.1% | 0.1% | 0.0% | 0.5% | 1.6% | 7.0% | 17.5% | 49.4% | ||
| High | N=472 | 186.6±34.1 | 201.8±32.7 | 207.5±29.2 | 207.1±33.2 | 206.6±44.6 | 203.8±32.0 | 194.5±31.5 | 175.0±27.0 |
| 0.0% | 0.8% | 1.7% | 8.5% | 18.9% | 32.1% | 53.0% | 80.8% | ||
| Age at exam (years) | 31.4±4.1 | 38.8±4.5 | 43.0±4.8 | 46.5±4.7 | 50.3±4.6 | 54.2±4.8 | 57.7±4.2 | 64.0±4.3 | |
means and standard deviations for non-HDL cholesterol and age data. Non-HDL values for participants on treatment inflated by non-parametric adjustment.